ArticleCureus2026
Recurrence of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis Following Kidney Transplantation: A Case Report With an Institutional Registry Review From Saudi Arabia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Recurrence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) following kidney transplantation is uncommon but may result in significant graft dysfunction and poor clinical outcomes. Data regarding recurrence after transplantation remains limited, particularly in the Middle East. Methods We present a case of early recurrent ANCA-associated glomerulonephritis following kidney transplantation, supported by a retrospective review of our institutional kidney transplant registry at King Fahad Specialist Hospital in Dammam, Saudi Arabia. Between 2008 and 2026, six patients underwent kidney transplantation for AAV-related end-stage kidney disease among 2306 kidney transplant recipients. Results Among 2306 kidney transplantations performed during the study period, six patients underwent transplantation for AAV-related end-stage kidney disease. Recurrence occurred in one patient (16.7%) and presented early in the post-transplant period with severe graft dysfunction. Histopathological evaluation demonstrated crescentic glomerulonephritis consistent with recurrent disease. Despite treatment with pulse corticosteroids and plasma exchange, the patient's clinical course was complicated by severe infectious complications resulting in death. The remaining five patients demonstrated generally favorable graft outcomes without evidence of recurrence during follow-up. Conclusion Recurrence of AAV after kidney transplantation remains uncommon. Although only one recurrence was identified in our cohort, the disease followed an aggressive clinical course in this patient, underscoring the importance of early recognition and prompt histological confirmation. Larger multicenter studies are needed to better define recurrence risk and optimize management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.